JP2017512202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512202A5 JP2017512202A5 JP2016554261A JP2016554261A JP2017512202A5 JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5 JP 2016554261 A JP2016554261 A JP 2016554261A JP 2016554261 A JP2016554261 A JP 2016554261A JP 2017512202 A5 JP2017512202 A5 JP 2017512202A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- sequence
- cholesterol
- nucleic acid
- immune response
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461946372P | 2014-02-28 | 2014-02-28 | |
| US61/946,372 | 2014-02-28 | ||
| PCT/EP2015/054131 WO2015128461A1 (en) | 2014-02-28 | 2015-02-27 | Immunostimulatory plasmids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017512202A JP2017512202A (ja) | 2017-05-18 |
| JP2017512202A5 true JP2017512202A5 (https=) | 2018-04-05 |
| JP6772065B2 JP6772065B2 (ja) | 2020-10-21 |
Family
ID=52598746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016554261A Expired - Fee Related JP6772065B2 (ja) | 2014-02-28 | 2015-02-27 | 免疫賦活プラスミド |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10155950B2 (https=) |
| EP (1) | EP3110940A1 (https=) |
| JP (1) | JP6772065B2 (https=) |
| KR (1) | KR20160122849A (https=) |
| CN (1) | CN106029867B (https=) |
| AU (1) | AU2015222102B2 (https=) |
| BR (1) | BR112016019837A2 (https=) |
| CA (1) | CA2940794C (https=) |
| CL (1) | CL2016002146A1 (https=) |
| CR (1) | CR20160393A (https=) |
| DO (1) | DOP2016000223A (https=) |
| IL (1) | IL247065A0 (https=) |
| MX (1) | MX2016010993A (https=) |
| PE (1) | PE20170404A1 (https=) |
| PH (1) | PH12016501705A1 (https=) |
| RU (1) | RU2740492C2 (https=) |
| SV (1) | SV2016005263A (https=) |
| UA (1) | UA118374C2 (https=) |
| WO (1) | WO2015128461A1 (https=) |
| ZA (1) | ZA201605495B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160122849A (ko) * | 2014-02-28 | 2016-10-24 | 바이엘 애니멀 헬스 게엠베하 | 면역자극성 플라스미드 |
| TR201908550T4 (tr) | 2014-06-04 | 2019-07-22 | Exicure Inc | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. |
| US11213593B2 (en) | 2014-11-21 | 2022-01-04 | Northwestern University | Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| KR20180021874A (ko) * | 2015-06-26 | 2018-03-05 | 바이엘 애니멀 헬스 게엠베하 | 시토졸 dna 감시 분자의 조절 방법 |
| SG10202000891UA (en) * | 2015-07-31 | 2020-03-30 | Bayer Animal Health Gmbh | Enhanced immune response in porcine species |
| EP3328423B1 (en) * | 2015-07-31 | 2021-05-26 | Bayer Animal Health GmbH | Enhanced immune response in fish |
| TWI759317B (zh) * | 2016-07-26 | 2022-04-01 | 德商拜耳動物保健有限公司 | 牛物種中增加的生育力 |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| CR20200260A (es) * | 2017-12-15 | 2020-08-01 | Bayer Animal Health Gmbh | Composiciones inmunoestimulantes |
| CN109646435B (zh) * | 2019-01-11 | 2021-08-03 | 山东省农业科学院奶牛研究中心 | 厄他培南钠在制备防治牛传染性鼻气管炎药物中的应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5427791A (en) | 1992-08-05 | 1995-06-27 | Regents Of The University Of Minnesota | Embryonal vaccine against Newcastle disease |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6645933B1 (en) * | 1995-08-01 | 2003-11-11 | Helsinki University Licensing Ltd. Oy | Receptor ligand VEGF-C |
| US5830878A (en) | 1995-06-07 | 1998-11-03 | Megabios Corporation | Cationic lipid: DNA complexes for gene targeting |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US6048535A (en) | 1997-06-12 | 2000-04-11 | Regents Of The University Of Minnesota | Multivalent in ovo avian vaccine |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20040247662A1 (en) | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
| ATE397942T1 (de) | 1999-03-26 | 2008-07-15 | Vical Inc | Adjuvanszusammensetzungen zur erhöhung der immunantwort bezüglich polynukleotid-basierenden impfstoffen |
| US20040002472A1 (en) | 2000-01-21 | 2004-01-01 | Audonnet Jean-Christophe Francis | Vaccination or immunization using a prime-boost regimen |
| US6517218B2 (en) | 2000-03-31 | 2003-02-11 | Relume Corporation | LED integrated heat sink |
| CN1636050A (zh) * | 2001-04-24 | 2005-07-06 | 基因创新有限公司 | 核心糖基化hcv包膜蛋白 |
| WO2003004051A2 (en) | 2001-07-02 | 2003-01-16 | Pfizer Products Inc. | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| AU2002953015A0 (en) * | 2002-12-02 | 2002-12-12 | Women's And Children's Hospital | Modified lacz gene |
| CN1764474B (zh) | 2003-03-26 | 2011-02-02 | 惠氏公司 | 免疫原性组合物及方法 |
| CA2542099A1 (en) | 2003-10-11 | 2005-04-21 | Inex Pharmaceuticals Corporation | Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| US20050181035A1 (en) | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
| WO2006017857A2 (en) | 2004-08-13 | 2006-02-16 | The Trustees Of The University Of Pennsylvania | Antibiotic resistance free dna vaccines |
| US20090068223A1 (en) | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| TWM297441U (en) | 2006-03-30 | 2006-09-11 | Cheng-Jiun Jian | LED projection light source module |
| US7663229B2 (en) | 2006-07-12 | 2010-02-16 | Hong Kong Applied Science And Technology Research Institute Co., Ltd. | Lighting device |
| US20090275642A1 (en) * | 2006-10-06 | 2009-11-05 | Reisfeld Ralph A | Dna composition for eliciting an immune response against tumor-associated macrophages |
| WO2009046388A1 (en) * | 2007-10-03 | 2009-04-09 | United States Medical Research & Material Command | Cr-2 binding peptide p28 as molecular adjuvant for dna vaccines |
| EP2257306B1 (en) | 2008-03-25 | 2014-05-07 | Juvaris Biotherapeutics, Inc. | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) |
| MX2011004316A (es) | 2008-10-31 | 2011-06-16 | Boehringer Ingelheim Vetmed | Uso de antigenos diversos que incluyen antigenos de mycoplasma bovis en composicion de vacuna multivalente. |
| WO2010130374A1 (en) * | 2009-05-14 | 2010-11-18 | Bayer Animal Health Gmbh | Enhanced immune response in avian species |
| BR112013016231B1 (pt) | 2010-12-22 | 2021-03-23 | Bayer Intellectual Property Gmbh | Composição imunomoduladora para o tratamento de doença respiratória bovina |
| CL2011000065A1 (es) | 2011-01-11 | 2011-04-15 | Univ Concepcion | Formulacion veterinaria para la prevencion y eliminacion de infeccion por cepas de e. coli stec, que comprende un plasmido recombinante que codifica un factor de virulencia y liposoma cationico como vehiculo, uso de dicha formulacion para tratar preferentemente bovinos y porcinos. |
| KR20160122849A (ko) * | 2014-02-28 | 2016-10-24 | 바이엘 애니멀 헬스 게엠베하 | 면역자극성 플라스미드 |
-
2015
- 2015-02-27 KR KR1020167026797A patent/KR20160122849A/ko not_active Withdrawn
- 2015-02-27 US US14/633,920 patent/US10155950B2/en active Active
- 2015-02-27 AU AU2015222102A patent/AU2015222102B2/en not_active Ceased
- 2015-02-27 CN CN201580010413.0A patent/CN106029867B/zh not_active Expired - Fee Related
- 2015-02-27 RU RU2016138321A patent/RU2740492C2/ru active
- 2015-02-27 CR CR20160393A patent/CR20160393A/es unknown
- 2015-02-27 CA CA2940794A patent/CA2940794C/en active Active
- 2015-02-27 MX MX2016010993A patent/MX2016010993A/es unknown
- 2015-02-27 PE PE2016001534A patent/PE20170404A1/es not_active Application Discontinuation
- 2015-02-27 WO PCT/EP2015/054131 patent/WO2015128461A1/en not_active Ceased
- 2015-02-27 BR BR112016019837A patent/BR112016019837A2/pt not_active Application Discontinuation
- 2015-02-27 EP EP15707606.8A patent/EP3110940A1/en not_active Ceased
- 2015-02-27 JP JP2016554261A patent/JP6772065B2/ja not_active Expired - Fee Related
- 2015-02-27 UA UAA201609729A patent/UA118374C2/uk unknown
-
2016
- 2016-08-02 IL IL247065A patent/IL247065A0/en unknown
- 2016-08-08 ZA ZA2016/05495A patent/ZA201605495B/en unknown
- 2016-08-24 CL CL2016002146A patent/CL2016002146A1/es unknown
- 2016-08-26 DO DO2016000223A patent/DOP2016000223A/es unknown
- 2016-08-26 PH PH12016501705A patent/PH12016501705A1/en unknown
- 2016-08-26 SV SV2016005263A patent/SV2016005263A/es unknown
-
2018
- 2018-04-25 US US15/962,414 patent/US10851379B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017512202A5 (https=) | ||
| RU2016138321A (ru) | Иммуностимулирующие плазмиды | |
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| Schwendener | Liposomes as vaccine delivery systems: a review of the recent advances | |
| JP4294584B2 (ja) | 核酸ワクチン接種の免疫応答を高めるための方法 | |
| JP7817257B2 (ja) | ｍＲＮＡワクチンを送達するための脂質ナノ粒子 | |
| RU2013133730A (ru) | Повышение иммунного отклика у видов крупного рогатого скота | |
| JP2014522842A5 (https=) | ||
| JP2014520807A5 (https=) | ||
| CN101616687B (zh) | 非特异性免疫刺激剂 | |
| EP4153224A1 (en) | Coronavirus antigen compositions and their uses | |
| EP4091630A1 (en) | Vaccines comprising r-dotap | |
| MXPA05013746A (es) | Conjugados de esfingoide-polialquilamina para vacunacion. | |
| US20190125858A1 (en) | Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery | |
| RU2014135522A (ru) | Промоторы для увеличенной экспрессии белка у менингококка | |
| JP2018518511A5 (https=) | ||
| RU2018102915A (ru) | Способы модуляции контрольных молекул цитозольной днк | |
| US11111277B2 (en) | Influenza vaccines | |
| Lee et al. | Perspective of peptide vaccine composed of epitope peptide, CpG-DNA, and liposome complex without carriers | |
| AR105568A1 (es) | Un método para provocar una respuesta inmunitaria en un sujeto receptor de especie porcina | |
| KR20210027168A (ko) | 신규한 핵산을 기반으로 하는 인플루엔자 백신 조성물 | |
| US20230181722A1 (en) | Coronavirus antigen compositions and their uses | |
| EP3035960A2 (en) | Respiratory syncytial virus (rsv) vaccine | |
| US20240316178A1 (en) | Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof | |
| HK40083470A (en) | Vaccines comprising r-dotap |